Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Configurable caged ball insert for a downhole tool
Integrated wire carrier for electrode array
Tread portion of an automobile tire
Correcting color plate data for mis-registration in a sub-scanning direction by performing a pixel transition at the transition point aligned in the main-scanning direction
Cover panel for frame based door lock
Fluid intake and content management system
Notification systems and methods that consider traffic flow predicament data
  Randomly Featured Patents
Toxoplasma gondii mutant with enhanced homologous recombination and uses thereof
Method and circuit for storing and providing historical physiological data
Etchant for production of electrode plate structure for liquid crystal display device
Determining feasibility of IC edits
Throwing toy
Multiplex flow assays preferably with magnetic particles as solid phase
Vesicular recording materials
Large scale supply planning
Apparatus for marinating meat products
Catapult toy